Pfizer weight loss drug may be as effective as competitors: Study | Englishheadline


Yahoo Finance Live health care reporter Anjalee Khemlani details the clinical trial results of Pfizer’s weight loss drug Danuglipron, how it compares to Novo Nordisk’s Ozempic, and examines the adoption of weight loss drugs in the health and wellness space.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top
%d bloggers like this: